Chevy Chase Trust’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-288,321
Closed -$3.36M 645
2024
Q4
$3.36M Sell
288,321
-522,712
-64% -$6.09M 0.01% 544
2024
Q3
$16.7M Sell
811,033
-231,592
-22% -$4.76M 0.05% 305
2024
Q2
$23.3M Sell
1,042,625
-31,985
-3% -$716K 0.07% 216
2024
Q1
$29.6M Buy
1,074,610
+83,435
+8% +$2.3M 0.1% 186
2023
Q4
$30.2M Sell
991,175
-11,780
-1% -$359K 0.11% 172
2023
Q3
$31.7M Buy
1,002,955
+29,412
+3% +$930K 0.13% 153
2023
Q2
$39.7M Buy
973,543
+36,477
+4% +$1.49M 0.15% 135
2023
Q1
$34.9M Sell
937,066
-35,010
-4% -$1.3M 0.14% 144
2022
Q4
$33.9M Sell
972,076
-165,399
-15% -$5.77M 0.14% 143
2022
Q3
$63.7M Buy
1,137,475
+101,170
+10% +$5.66M 0.27% 88
2022
Q2
$53.6M Sell
1,036,305
-20,463
-2% -$1.06M 0.22% 99
2022
Q1
$76.8M Sell
1,056,768
-81,336
-7% -$5.91M 0.26% 89
2021
Q4
$135M Sell
1,138,104
-20,628
-2% -$2.44M 0.43% 49
2021
Q3
$155M Sell
1,158,732
-87,839
-7% -$11.8M 0.54% 35
2021
Q2
$202M Sell
1,246,571
-77,858
-6% -$12.6M 0.69% 26
2021
Q1
$106M Sell
1,324,429
-311,443
-19% -$25M 0.38% 58
2020
Q4
$89M Sell
1,635,872
-168,384
-9% -$9.16M 0.32% 75
2020
Q3
$35.9M Buy
1,804,256
+246,093
+16% +$4.89M 0.14% 152
2020
Q2
$32.8M Buy
1,558,163
+173,351
+13% +$3.64M 0.13% 161
2020
Q1
$16.9M Buy
1,384,812
+51,987
+4% +$636K 0.08% 237
2019
Q4
$19.6M Buy
1,332,825
+78,058
+6% +$1.15M 0.07% 265
2019
Q3
$16.8M Buy
1,254,767
+154,922
+14% +$2.07M 0.07% 287
2019
Q2
$18M Buy
1,099,845
+143,334
+15% +$2.35M 0.07% 274
2019
Q1
$14.7M Buy
956,511
+261,175
+38% +$4.02M 0.06% 320
2018
Q4
$9.49M Sell
695,336
-46,688
-6% -$637K 0.05% 379
2018
Q3
$21.2M Buy
742,024
+86,142
+13% +$2.47M 0.09% 237
2018
Q2
$17.9M Buy
655,882
+67,714
+12% +$1.85M 0.08% 270
2018
Q1
$12.4M Buy
+588,168
New +$12.4M 0.06% 357